scispace - formally typeset
S

Stephan Michels

Researcher at Medical University of Vienna

Publications -  72
Citations -  4842

Stephan Michels is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Macular degeneration & Choroidal neovascularization. The author has an hindex of 23, co-authored 72 publications receiving 4683 citations. Previous affiliations of Stephan Michels include University of Miami.

Papers
More filters
Journal ArticleDOI

An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration.

TL;DR: In this paper, an optical coherence tomography (OCT)-guided, variable-dosing regimen with intravitreal ranibizumab for the treatment of patients with age-related macular degeneration (AMD) was evaluated.
Journal ArticleDOI

Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Week Results of an Uncontrolled Open-Label Clinical Study

TL;DR: Overall, bevacizumab therapy was well tolerated, with an improvement in VA, OCT, and angiographic outcomes, and although these preliminary results are promising, a randomized controlled clinical trial is necessary before concluding that systemic bevicizumAB therapy is safe and effective for patients with neovascular AMD.
Journal ArticleDOI

Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin - 1-year results of a randomized clinical trial - VIP report no. 1

Jennifer J. Arnold, +292 more
- 01 Jan 2001 - 
TL;DR: Because photodynamic therapy with verteporfin can safely increase the chance of stabilizing or improving vision in patients with subfoveal CNV from pathologic myopia compared with a placebo, it is recommended ophthalmologists consider vertEPorfin therapy for treatment of such patients.
Journal ArticleDOI

Influence of Photodynamic Therapy on Expression of Vascular Endothelial Growth Factor (VEGF), VEGF Receptor 3, and Pigment Epithelium–Derived Factor

TL;DR: PDT using verteporfin induces a reproducible angiogenic response in elderly human eyes and VEGF, VEGFR-3, and PEDF expression is enhanced after PDT.
Journal ArticleDOI

Three-dimensional ultrahigh-resolution optical coherence tomography of macular diseases.

TL;DR: High-speed UHR OCT offers unprecedented, realistic, 3-D imaging of ocular diseases at all epi-, intra- and subretinal levels and allows a comprehensive analysis of focal and diffuse diseases, as well as identification of dynamic pathomechanisms.